Correlation Between Sinocelltech and Ningbo MedicalSystem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sinocelltech and Ningbo MedicalSystem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinocelltech and Ningbo MedicalSystem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinocelltech Group and Ningbo MedicalSystem Biotechnology, you can compare the effects of market volatilities on Sinocelltech and Ningbo MedicalSystem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinocelltech with a short position of Ningbo MedicalSystem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinocelltech and Ningbo MedicalSystem.

Diversification Opportunities for Sinocelltech and Ningbo MedicalSystem

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Sinocelltech and Ningbo is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Sinocelltech Group and Ningbo MedicalSystem Biotechno in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ningbo MedicalSystem and Sinocelltech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinocelltech Group are associated (or correlated) with Ningbo MedicalSystem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ningbo MedicalSystem has no effect on the direction of Sinocelltech i.e., Sinocelltech and Ningbo MedicalSystem go up and down completely randomly.

Pair Corralation between Sinocelltech and Ningbo MedicalSystem

Assuming the 90 days trading horizon Sinocelltech is expected to generate 1.07 times less return on investment than Ningbo MedicalSystem. In addition to that, Sinocelltech is 1.16 times more volatile than Ningbo MedicalSystem Biotechnology. It trades about 0.07 of its total potential returns per unit of risk. Ningbo MedicalSystem Biotechnology is currently generating about 0.09 per unit of volatility. If you would invest  931.00  in Ningbo MedicalSystem Biotechnology on September 25, 2024 and sell it today you would earn a total of  156.00  from holding Ningbo MedicalSystem Biotechnology or generate 16.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Sinocelltech Group  vs.  Ningbo MedicalSystem Biotechno

 Performance 
       Timeline  
Sinocelltech Group 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sinocelltech Group are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sinocelltech sustained solid returns over the last few months and may actually be approaching a breakup point.
Ningbo MedicalSystem 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ningbo MedicalSystem Biotechnology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ningbo MedicalSystem sustained solid returns over the last few months and may actually be approaching a breakup point.

Sinocelltech and Ningbo MedicalSystem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sinocelltech and Ningbo MedicalSystem

The main advantage of trading using opposite Sinocelltech and Ningbo MedicalSystem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinocelltech position performs unexpectedly, Ningbo MedicalSystem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ningbo MedicalSystem will offset losses from the drop in Ningbo MedicalSystem's long position.
The idea behind Sinocelltech Group and Ningbo MedicalSystem Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios